Shr profit seven cts vs n/a    Net profit 587,000 vs profit 3,231,000
    Sales 18.5 mln vs 18.7 mln
    Nine Mths
    Shr loss 39 ct s vs n/a
    Net loss 2,368,000 vs protit 7,165,000
    Sales 55.4 mln vs 54.2 mln
    Note: Current nine month figures include extraordinary loss
of 1.2 mln dlrs, or 17 cts per share, resulting from costs
associated with restructuring.
    Prior quarter and nine month per share figures not
applicable because company began operations in October, 1986
with the acquisition of Gould Inc's &lt;GLD> medical products
group.
 Reuter
